Enrichment and purification of peptide impurities using twin-column continuous chromatography.

Continuous chromatography Impurity isolation Impurity profiling N-Rich Peptide purification

Journal

Journal of chromatography. A
ISSN: 1873-3778
Titre abrégé: J Chromatogr A
Pays: Netherlands
ID NLM: 9318488

Informations de publication

Date de publication:
29 Mar 2022
Historique:
received: 30 12 2021
revised: 08 02 2022
accepted: 09 02 2022
pubmed: 27 2 2022
medline: 15 3 2022
entrez: 26 2 2022
Statut: ppublish

Résumé

N-Rich is a twin-column chromatography process that enriches target compounds relative to other components in a mixture, thereby facilitating their isolation and characterization. This study demonstrates the performance of N-Rich for isolation of Angiotensin II peptide impurities compared with standard analytical and preparative chromatography approaches. Peptides have diverse chemical properties and are produced using a wide range of methods, resulting in products with complex impurity profiles. The characterization of impurities for clinical development is essential but obtaining high purity samples in sufficient quantities is often a difficult task when using standard chromatographic techniques. In contrast, by using cyclic continuous chromatography with UV-based process control, N-Rich enables automatic on-column accumulation of target impurities while other compounds in the mixture are depleted. This has multiple advantages compared to standard techniques. Firstly, at the end of the cyclic accumulation phase the highly enriched target is eluted in one step with high purity and concentration. This means fewer fractions for analysis are generated and up-concentration steps are reduced. Secondly, the purification of target impurities using semi-preparative scale chromatography becomes viable, even if initial resolution is poor compared to analytical HPLC. This allows for very significant increases in productivity for purification of difficult to isolate impurities. This study demonstrates two N-Rich strategies: Example 1: Purification of µg quantities of multiple Angiotensin II impurities with a >9-fold increase in productivity compared to analytical HPLC. Example 2: Specific isolation of 1 mg of a critical impurity at 88% purity. 79-fold increase in productivity and a 69-fold reduction in solvent consumption compared to analytical HPLC.

Identifiants

pubmed: 35219108
pii: S0021-9673(22)00092-9
doi: 10.1016/j.chroma.2022.462894
pii:
doi:

Substances chimiques

Peptides 0
Solvents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

462894

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Richard Weldon (R)

ChromaCon AG, Technoparkstr. 1, Zurich CH-8005, Switzerland.

Thomas Müller-Späth (T)

ChromaCon AG, Technoparkstr. 1, Zurich CH-8005, Switzerland. Electronic address: thomas.mueller-spaeth@chromacon.com.

Articles similaires

Animals Huntington Disease Mitochondria Neurons Mice
Humans Chromatography, High Pressure Liquid Acetaminophen COVID-19 SARS-CoV-2
Animals Adjuvants, Immunologic Mice Antigen-Presenting Cells Antigen Presentation
Hemolysin Proteins Artificial Cells Protein Engineering Protein Transport Cell Membrane

Classifications MeSH